Kala Bio Analyst Price Targets - Benzinga

Kala Bio Inc

KALANASDAQ

Trade with Public

Trade with Public

$0.1897

0.00422.26%

最終更新: Oct 23, 6:35 PM

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較株式レポート

Kala Bio Analyst Price Targets - Benzinga

Kala Bio Analyst Price Targets

Wall Street analyst price targets and consensus rating for Kala Bio (KALA).

Price Target Range — 7 Quarters

Analyst Consensus — 3 Analysts

2Buy

1Hold

Consensus RatingOutperform# Analysts3Avg. Consensus PT$1300Upside to Avg. PT+670003.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 29, 2025	HC Wainwright & Co.	Yi Chen	Downgrade	Buy→Neutral	—
Sep 17, 2025	HC Wainwright & Co.	Yi Chen	PT Raise	Buy	$600→$1750
Sep 11, 2025	Oppenheimer	Andreas Argyrides	PT Raise	Outperform	$750→$1650
Sep 8, 2025	Mizuho	Graig Suvannavejh	Initiate	Outperform	$1500
Jun 2, 2025	Oppenheimer	Andreas Argyrides	Assumes	Outperform	$750
May 23, 2025	HC Wainwright & Co.	Yi Chen	PT Cut	Buy	$750→$600
Apr 4, 2025	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$750
Feb 13, 2025	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$750
Nov 15, 2024	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$750
Aug 19, 2024	Oppenheimer	Francois Brisebois	Maintained	Outperform	$750
May 17, 2024	HC Wainwright & Co.	Yi Chen	PT Cut	Buy	$1050→$900
Apr 2, 2024	HC Wainwright & Co.	Yi Chen	PT Cut	Buy	$1100→$1050
Apr 1, 2024	Oppenheimer	Francois Brisebois	Maintained	Outperform	$750
Nov 17, 2023	HC Wainwright & Co.	Yi Chen	PT Cut	Buy	$1200→$1100

Analyst Ratings News

PRO
HC Wainwright & Co. Maintains Buy on Kala Bio, Raises Price Target to $35

HC Wainwright & Co. analyst Yi Chen maintains Kala Bio (NASDAQ:KALA) with a Buy and raises the price target from $12 to $35.

Benzinga Newsdesk

PRO
Oppenheimer Maintains Outperform on Kala Bio, Raises Price Target to $33

Oppenheimer analyst Andreas Argyrides maintains Kala Bio (NASDAQ:KALA) with a Outperform and raises the price target from $15 to $33.

Benzinga Newsdesk

PRO
Mizuho Initiates Coverage On Kala Bio with Outperform Rating, Announces Price Target of $30

Mizuho analyst Graig Suvannavejh initiates coverage on Kala Bio (NASDAQ:KALA) with a Outperform rating and announces Price Target of $30.

Benzinga Newsdesk

This Harrow Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Avi Kapoor

PRO
Ladenburg Thalmann Initiates Coverage On Kala Bio with Buy Rating, Announces Price Target of $12

Ladenburg Thalmann analyst Aydin Huseynov initiates coverage on Kala Bio (NASDAQ:KALA) with a Buy rating and announces Price Target of $12.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Kala Bio, Lowers Price Target to $12

HC Wainwright & Co. analyst Yi Chen maintains Kala Bio (NASDAQ:KALA) with a Buy and lowers the price target from $15 to $12.

Benzinga Newsdesk